News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hagop Kantarjian: In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia
Photo of Hagop Kantarjian from mdanderson.org
Mar 10, 2024, 20:49

Hagop Kantarjian: In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia

 

Hagop Kantarjian, a Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, recently posted on X:

“In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia. ”

Source: Hagop Kantarjian/X

Acute Myeloid Leukemia AML cancer cedazuridine decitabine fully-oral regimen Hagop Kantarjian Hematology older/unfit population OncoDaily Oncology phase 2 study venetoclax
Special Coverage
Blog
Dec 2, 2024, 10:01
Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg
Blog
Dec 2, 2024, 09:57
Michael Shusterman: GI Oncology standard regimen doses remain too high for many real world patients
Blog
Dec 2, 2024, 09:07
Support Children Battling Cancer and their Parents with The Goodwill Foundation - Onco Intelligence
Blog
Dec 2, 2024, 09:04
How can mpMRI change management of patients with NMIBC or MIBC?
Blog
Dec 2, 2024, 08:15
Nikhil Vojjala: Excited to win the Michigan state ACP Doctors dilemma championship
Insight
Dec 2, 2024, 08:12
Mattia Rediti: Our work describing HER2-positive Breast Cancer heterogeneity is out
Insight
Dec 2, 2024, 08:01
Enrique Soto: Our systematic review on the use of wearable technologies in older adults with Cancer
Insight
Dec 2, 2024, 07:43
Bishoy M. Faltas: We are looking for Postdocs Interested in studying Cancer Evolution
Blog
Dec 2, 2024, 07:40
Caitlin Delaney: I am launching my fundraiser for off-label treatments which will hopefully extend my life
Opinion
Dec 1, 2024, 22:10
Mike Thompson: Myeloma/Plasma Cell Dyscrasia Draft Table Update
Blog
Dec 1, 2024, 22:10
Ibrahim Halil Sahin: Advances in Colorectal Cancer Precision Medicine
Blog
Dec 1, 2024, 22:10
Promising Outcomes in APL Treatment - ACS Journal Cancer